Ekso Bionics Holdings Inc reports results for the quarter ended in December - Earnings Summary

Chronoscale

25/02/2022 24:12

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 23 cents​​ per share for the quarter ended in
December. The lone analyst forecast for the quarter was for a
loss of 25 cents per share.
    * Revenue rose 80.8% to $4.08 million from a year ago; 
analysts
expected $2.80 million. 
    * Ekso Bionics Holdings Inc's reported EPS for the quarter
was a
loss of 23 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ekso Bionics Holdings Inc shares had fallen by 9.1% this
quarter.
    * The company reported a quarterly loss of $2.86 million.
    * Wall Street's median 12-month price target for Ekso
Bionics
Holdings Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 25 at 12:12 a.m.
 ​All figures in US dollars unless otherwise stated